Abstract
Our recent study in individuals with major depressive disorder (MDD) elicited six prioritized attributes in selecting treatments to manage their condition: Treatment Mode, Time to Treatment Effect, MDD Relief, Quality of Work, Interaction with Others, and Affordability. This study aims to identify whether previous cost-effectiveness analyses (CEAs) in MDD addressed these patient-important attributes, whether patients were engaged in the modeling process, and whether patient preferences for treatment attributes were incorporated into the economic evaluations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have